| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.0093 | 0.9 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | -0.0063 | 0.9 |
| mRNA | AMG-706 | GDSC1000 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.0059 | 0.9 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | 0.0059 | 0.9 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | 0.006 | 0.9 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | -0.0074 | 0.9 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | 0.0062 | 0.9 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.0062 | 0.9 |